Connect your AI

Theravance Biopharma TBPH Earnings yield

Earnings yield at other companies

Zevra Therapeutics, Inc.ZVRA

22.7%+15.1pp

LQD

Liquidia CorporationLQDA

-6.2%-2.3pp

Royalty PharmaRPRX

4%-4.1pp

United TherapeuticsUTHR

5%-3.8pp

Aurinia PharmaceuticalsAUPH

15.1%+11.5pp

PrecigenPGEN

-14.9%-5.5pp

Other financials

Income statement

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Calculated from Theravance Biopharma’s reported figures.

net income/market cap=13.7%

Based on trailing twelve months.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Theravance Biopharma's earnings yield?: Theravance Biopharma (TBPH) reported earnings yield of 13.7% in Q1 2026.
How has Theravance Biopharma's earnings yield changed year-over-year?: Theravance Biopharma's earnings yield increased by 203.8% year-over-year, from -13.2% to 13.7%.
What is the long-term trend for Theravance Biopharma's earnings yield?: Over 5 years (2020 to 2025), Theravance Biopharma's earnings yield has grown at a -14.4% compound annual growth rate (CAGR), from -24.3% to 11.2%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.